Top

October 2018

XtalPi integrates quantum physics and AI to create computational drug discovery and development applications that accurately predict important drug properties of small molecules, helping researchers accelerate and de-risk pharmaceutical innovations.

XtalPi announces the closing of $46 million Series B-1 extension to drive growth and accelerate platform development

CAMBRIDGE, Mass., Oct 24, 2018 – XtalPi Inc, a computation-driven biotech startup integrating quantum physics, artificial intelligence (AI), and cloud computing to empower pharmaceutical research, today announced a Series B-1 extension financing of $46 million to support XtalPi’s continuous market growth and expand the application...

Read More